Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

COVID-19 × Azithromycin × Other hematologic neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Hematologic Neoplasms 1 COVID-19 1

Interventions

cilgavimab and tixagevimab drug combination 2 Standard of Care 2 Specimen Handling 2 Practice Guidelines as Topic 2 CVnCoV COVID-19 vaccine 2 COH04S1 COVID-19 vaccine 2 BNT162 Vaccine 2 sotrovimab 1 ogalvibart 1 crexavibart 1 bemcentinib 1 Therapeutics 1 Hydroxychloroquine 1 HuMax-IL8 1 Data Collection 1 COVID-19 Vaccines 1 Blood Specimen Collection 1 Azithromycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04392128 2020-09-04

HYACINTHE

Institut de cancérologie Strasbourg Europe

Phase 2 Withdrawn

Other hematologic neoplasm

COVID-19, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡